Atlas Trials

Stage II

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II

RecordFirmDate
Anti PD-1 Neo-adjuvant Treatment for NSCLC (NCT02938624)Jair Bar, M.D., Ph.D.2017-01-07

Track Stage II automatically

Every clearance here is in the API, with alerts when new ones post.